Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma of Soft Tissue”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02287311
What this trial is testing

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaSevere Chronic Active Epstein Barr Virus+3 more
Baylor College of Medicine 38
Early research (Phase 1)Study completedNCT00004241
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more
National Cancer Institute (NCI) 60
Not applicableActive Not RecruitingNCT04671693
What this trial is testing

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

Who this might be right for
Late EffectsTesticular Germ Cell Tumor MixedNon-Metastatic Breast Carcinoma+6 more
Centre Leon Berard 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04195555
What this trial is testing

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
National Cancer Institute (NCI) 3
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT00261807
What this trial is testing

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

Who this might be right for
Fasciitis, NecrotizingSevere Necrotizing Skin and Soft Tissue InfectionsFournier's Gangrene
University of Maryland, Baltimore 25
Not applicableUnknownNCT01295463
What this trial is testing

Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Who this might be right for
Cancer
Institut Català d'Oncologia 96
Testing effectiveness (Phase 2)Study completedNCT00365768
What this trial is testing

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Columbia University 56
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01447056
What this trial is testing

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaLymphoproliferative Disorder+3 more
Baylor College of Medicine 37
Early research (Phase 1)Study completedNCT04681105
What this trial is testing

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Who this might be right for
Recurrent Acute LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Blastic Plasmacytoid Dendritic Cell Neoplasm+14 more
City of Hope Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing

CREATE: Cross-tumoral Phase 2 With Crizotinib

Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582
Testing effectiveness (Phase 2)Looking for participantsNCT04851119
What this trial is testing

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Who this might be right for
Colorectal CarcinomaEndometrial CarcinomaMelanoma+19 more
Children's Oncology Group 147
Not applicableLooking for participantsNCT00006518
What this trial is testing

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Who this might be right for
HIVKaposi's SarcomaLymphomas+2 more
National Cancer Institute (NCI) 1,029
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Early research (Phase 1)UnknownNCT03775525
What this trial is testing

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+14 more
Genzada Pharmaceuticals USA, Inc. 127
Not applicableLooking for participantsNCT06004011
What this trial is testing

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

Who this might be right for
Cervical CancerKaposi SarcomaNon Hodgkin Lymphoma
Implenomics 4,100
Not applicableStudy completedNCT01341119
What this trial is testing

Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma

Who this might be right for
Extranodal NK/T Cell Lymphoma
Samsung Medical Center 40
Not applicableStudy completedNCT00982449
What this trial is testing

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Who this might be right for
Hodgkin LymphomaNon Hodgkin LymphomaKaposi's Sarcoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Next Page